TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
▌TickerSpark Feed

KRYS coverage

Every article, report, and earnings note where KRYS appears.

Krystal Biotech (KRYS): VYJUVEK Growth Funds Pipeline
Research ReportKRYS

Krystal Biotech (KRYS): VYJUVEK Growth Funds Pipeline

Krystal Biotech pairs a profitable commercial launch with a deep gene-therapy pipeline, but valuation leaves less room for execution missteps. VYJUVEK is driving strong revenue growth while multiple programs advance toward key clinical milestones.

Nov 2, 2026·21 MIN
HealthcareBiotechnologyBiotechnology
Krystal Biotech's Q2 beat was not enough to save the stock
OpinionKRYS

Krystal Biotech's Q2 beat was not enough to save the stock

KRYS's 8.4% post-earnings drop says the market is pricing single-product risk harder than near-term growth. Vyjuvek is scaling, but a 21.23x sales multiple leaves little room for pipeline delays or reimbursement friction.

Aug 4, 2026·3 MIN
BiotechnologyValuationPipeline
Krystal Biotech, Inc. (KRYS) drops 8% after Q2 earnings
Trending StockKRYS

Krystal Biotech, Inc. (KRYS) drops 8% after Q2 earnings

Krystal Biotech, Inc. (KRYS) drops after its Q2 earnings report, even as revenue and profit rose year over year. The move came on heavy volume as investors reassessed the stock’s premium valuation and growth expectations for VYJUVEK and the broader pipeline.

Aug 3, 2026·5 MIN
▌On-Demand Research

Want a deeper dive on KRYS?

Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.

Generate KRYS Report
▌The Daily Briefing · Free

A new stock idea, every evening.

One stock worth watching each weekday, free in your inbox.

Creates a free TickerSpark account — newsletter included.

or with email

Daily market recap + weekly preview. One-click unsubscribe in every email.

▌For Active Investors

Stock research for every investor

  • Reports on any stock
  • Daily market intelligence
  • AI analyst in your pocket
  • Portfolio analysis tools
Get Full Access →

Cancel anytime

▌Today's Top MoverGPN
▲9.95%
Global Payments Inc. · $91.83

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA